Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (763)	1/25/2000 8:20:00 AM
From: John McCarthy	Read Replies (1) \| Respond to of 1494

AIDS DEMENTIA TREATMENTS Hi Cheryl - Thank you for your post. I was unaware of the article you cited and - more importantly - the benefits that the participants seemed to derive from Memantine. i.e. they wanted to continue to use Memantine. actupgg.org Along these lines I went to the company site this morning and found this press release from November 1998. It ties in with the information that you posted. ntii.com I am somewhat in a quandry because I do not have a real understanding as to whether or not we have a current ONGOING trial with respect to AIDS DEMENTIA. The pipeline portion of the web site indicates one ...... ntii.com But I cannot find any recent press releases about it. If anyone can offer insight - thanks! regards, John